Scilex Holding (SCLX) Cash & Current Investments (2020 - 2026)

Scilex Holding (SCLX) posted quarterly Cash & Current Investments of $145.1 million for Q1 2026, up 2401.26% year-over-year from $5.8 million in Q1 2025, and up 1200.52% on a QoQ basis from $11.2 million in Q4 2025.

Scilex Holding (SCLX) Cash & Current Investments (2020 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Cash & Current Investments for 7 consecutive years, with $145.1 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash & Current Investments rose 2401.26% year-over-year to $145.1 million; the TTM figure through Mar 2026 stood at $145.1 million (up 2401.26% YoY), while the FY2025 annual figure was $11.2 million, up 240.92% from the prior year.
  • Cash & Current Investments came in at $145.1 million for Q1 2026 at Scilex Holding, up from $11.2 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $145.1 million in Q1 2026, with the low at $69922.0 in Q3 2022.
  • Average Cash & Current Investments over 5 years is $29.9 million, with a median of $4.1 million recorded in 2025.
  • The largest YoY upside for Cash & Current Investments was 55034.43% in 2022 against a maximum downside of 98.48% in 2022.
  • Year by year, Cash & Current Investments stood at $2.2 million in 2022, then surged by 79.53% to $3.9 million in 2023, then retreated by 16.55% to $3.3 million in 2024, then surged by 240.92% to $11.2 million in 2025, then surged by 1200.52% to $145.1 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $145.1 million, $11.2 million, and $900000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 5.28 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 22.05 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 9.39 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 7.94 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 5.70 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 12.04 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 7.64 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 13.08 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - 100.00 Mn
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn 145.07 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 145.07 Mn
Dec 31, 2025 11.16 Mn
Sep 30, 2025 900,000.00
Jun 30, 2025 4.10 Mn
Mar 31, 2025 5.80 Mn
Dec 31, 2024 3.27 Mn
Sep 30, 2024 77,000.00
Jun 30, 2024 6.89 Mn
Mar 31, 2024 1.82 Mn
Dec 31, 2023 3.92 Mn
Sep 30, 2023 2.00 Mn
Jun 30, 2023 34.12 Mn
Mar 31, 2023 5.10 Mn
Dec 31, 2022 2.18 Mn
Sep 30, 2022 69,922.00
Jun 30, 2022 142.04 Mn
Mar 31, 2022 140.58 Mn
Dec 31, 2021 143.75 Mn
Sep 30, 2021 115,642.00
Jun 30, 2021 257,621.00